EZH2 and cancer: EZH2 can also promote the development and progression of cancer via chromatin modification including the epigenetic activation of the oncogenic signaling cascade and silencing of tumor suppressor genes; it has been implicated in cell proliferation, differentiation, invasion, and metastasis [11, 14, 15].